Suppr超能文献

维拉帕米对高血压患者的影响。

Effects of verapamil in hypertensive patients.

作者信息

de Leeuw P W, Birkenhäger W H

出版信息

Acta Med Scand Suppl. 1984;681:125-8. doi: 10.1111/j.0954-6820.1984.tb08686.x.

Abstract

In fifteen patients with uncomplicated essential hypertension verapamil reduced systolic as well as diastolic blood pressure by virtue of a decrease in total peripheral vascular resistance. Renal vascular resistance also fell, but renal perfusion was well maintained. Although levels of renin and angiotensin II remained unchanged, aldosterone levels fell significantly. Noradrenaline levels rose slightly, but changes were not significant. On the other hand adrenaline was significantly reduced. Renal sodium excretion was markedly enhanced, perhaps secondary to aldosterone suppression. Despite sodium loss, plasma volume increased suggesting that verapamil not only lowers arterial but also venous resistance.

摘要

在15例单纯原发性高血压患者中,维拉帕米通过降低总外周血管阻力降低了收缩压和舒张压。肾血管阻力也下降,但肾灌注维持良好。虽然肾素和血管紧张素II水平保持不变,但醛固酮水平显著下降。去甲肾上腺素水平略有上升,但变化不显著。另一方面,肾上腺素显著降低。肾钠排泄明显增加,可能继发于醛固酮抑制。尽管有钠丢失,但血浆容量增加,提示维拉帕米不仅降低动脉阻力,还降低静脉阻力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验